| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.3M | — | +40.4% |
| Cost of Revenue | $9.5M | — | +28.4% |
| Gross Profit | $14.7M | — | +49.4% |
| R&D Expense | $1.9M | — | +61.5% |
| SG&A Expense | $10.4M | — | +13.9% |
| Operating Income | $2.4M | — | +613.6% |
| Interest Expense | $1.1M | — | -2.3% |
| Pre-tax Income | $1.6M | — | +205.1% |
| Income Tax | $20K | — | -73.0% |
| Net Income | $1.6M | — | +198.9% |
| EPS (Basic) | $0.06 | — | +200.0% |
| EPS (Diluted) | $0.05 | — | +183.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.7M | -24.2% | +12.9% |
| Accounts Receivable | $13.4M | +14.0% | -18.2% |
| Inventory | $14.5M | -6.2% | +6.2% |
| Current Assets | $53.2M | -12.1% | +6.6% |
| Total Assets | $97.7M | +6.1% | +16.3% |
| Current Liabilities | $44.2M | +14.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $7.4M | — | +254.3% |
| Capital Expenditures | $75K | — | — |
| Investing Cash Flow | -$15.1M | — | — |
| Financing Cash Flow | $1.4M | — | +252.5% |
| Free Cash Flow | $7.3M | — | +250.7% |
| +74.3% |
| Long-term Debt | $18.9M | -13.0% | -36.9% |
| Total Liabilities | $67.1M | +1.7% | +12.6% |
| Stockholders' Equity | $30.6M | +17.1% | +25.2% |